# Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder

> **NCT06629207** · NA · RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 20 (estimated)

## Conditions studied

- Parkinson Disease
- REM Sleep Behavior Disorder
- Dementia, Lewy Body

## Interventions

- **DEVICE:** PET/CT with 18-FDG
- **DEVICE:** SPECT : 123 I-FP-CIT (DATSCAN)
- **DEVICE:** MRI

## Key facts

- **NCT ID:** NCT06629207
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-07
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06629207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06629207, "Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06629207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*